Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 406
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01196455 | Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast Cancer | ||
| NCT04245085 | ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma | ||
| NCT01384838 | Exercise Training in Postmenopausal Patients With Breast Cancer | ||
| NCT00391248 | Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL) | ||
| NCT03961698 | Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma | ||
| NCT05966233 | R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma | ||
| NCT01439776 | Add Vitamin D With Standard of Care for Chronic Hepatitis C Patients | ||
| NCT01048879 | Pharmacokinetics of Tamiflu® (Oseltamivir) in Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)and or Continuous Venovenous Hemodialysis (CVVHD) | ||
| NCT03554343 | Sun May Arise on SMA : Newborn Screening of Spinal Muscular Atrophy in Belgium | ||
| NCT03892525 | Study of Intratumoral Selicrelumab With Atezolizumab in Patients With Refractory or Relapsed B Cell Lymphoma | ||
| NCT00262717 | Can Resistance Enhance Selection of Treatment? (CREST) | ||
| NCT00405860 | CellCept in p-ANCA Vasculitis | ||
| NCT01752335 | Effect of Monoclonal Anti-IL6 Antibody (Tocilizumab) on the Cardiovascular Risk in Patients With Rheumatoid Arthritis | ||
| NCT04993274 | Sensitivity of Motor Assessment in MS - a Prospective Cohort Study | ||
| NCT06663098 | Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC). | ||
| NCT02894853 | Lung Cancer Early Molecular Assessment Trial | ||
| NCT03272477 | Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients | ||
| NCT01683175 | Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation | ||
| NCT02319941 | Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes | ||
| NCT03767075 | A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets) | ||
| NCT02049853 | The Triple A Initiative Study ("Aktionsbündnis Akute Atemnot") | ||
| NCT01471470 | Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer | ||
| NCT01101295 | The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia. | ||
| NCT02511756 | Visualization of Anti-angiogenic Effects With Perfusion Computed Tomography (CTP) | ||
| NCT02622581 | Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients | ||
| NCT00050167 | Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer | ||
| NCT04671693 | A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors. | ||
| NCT00944684 | High Dose Ribavirin in the Treatment of Chronic Hepatitis C | ||
| NCT01428414 | Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer | ||
| NCT01015339 | Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction | ||
| NCT07365930 | NIS on the Benefits of TIPS in Patients With HCC Receiving Atezo+Bev in 1st-Line Therapy | ||
| NCT01456312 | HBsAg Related Response Guided Therapy | ||
| NCT03197805 | Assessment of the Impact of RNA Genomic Profile on Treatment Decision-making in HER2 Equivocal Breast Cancer Patients | ||
| NCT01326559 | Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC) | ||
| NCT05050214 | Obinutuzumab in Primary MN | ||
| NCT01015352 | Azacitidine Combined to Epoetin Beta in International Prognostic Scoring System (IPSS) Low-risk and Intermediate-1 Myelodysplastic Syndrome (MDS) Patients, Resistant to Erythropoetin-stimulating Agents (ESA) | ||
| NCT00074438 | Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid Arthritis | ||
| NCT04389541 | Clinical Research Platform on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology | ||
| NCT00865982 | Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer | ||
| NCT02407080 | Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia | ||
| NCT01718379 | Lenalidomide in Subject With Low and Intermediate-1 Risk MDS and Without Chromosome 5 Abnormality. | ||
| NCT01458730 | Nordic Study in Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma | ||
| NCT04059081 | A Prospective Cohort of Obinutuzumab and Chlorambucil (GC) Chemotherapy for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia Including Next- Generation Sequencing (NGS)-Based Assessment | ||
| NCT00273767 | Preliminary Administration of EPO and Markers of Cardiac Ischemia Induced by CPB | ||
| NCT04808245 | A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas | ||
| NCT02436707 | Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma | ||
| NCT04341181 | ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling | ||
| NCT00484328 | Ribavirin, Its Dosing Regime | ||
| NCT02310503 | Spanish Registry of Mohs Surgery | ||
| NCT03455582 | Cognition Evolution and MRI Markers in PPMS Patients on 2 Years |
